Saul Helman

President at Epsilon Life Sciences

Speaker

Dr Helman brings a combination of global clinical, scientific, strategy, commercial, and compliance governance experience. Dr Helman has served on private and not-for-profit Boards over the last two decades and has served as a compliance expert to Boards in the Life Sciences Industry who are under government enforcement (e.g., Corporate Integrity Agreements), since the inception of this role. Dr Helman has launched and managed global marketing of billion-dollar products, established therapeutic area strategies, and led international new product planning. Dr Helman’s advisory career has focused on litigation, investigation and compliance support within the Health Care and Life Sciences industry, leading independent monitorships, serving as expert witness, and supporting Boards, C-suites and company leadership with compliance program development, implementation, and evaluation. Speaking regularly at industry conferences, Dr Helman has published extensively on the role of the Board of Directors as it relates to their fiduciary responsibilities and healthcare compliance. Dr Helman has also been sought out by the Office of Inspector General Health and Human Services to serve on a select panel of advisors to discuss risk and controls in the Health Care and Life Sciences industry.